QA: Cellectar Biosciences Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2023_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc

  xvar xval
0 AssetsCurrent 20,529,601
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 418,641
3 remainder_Assets 641,548
4 LiabilitiesCurrent 5,529,290
5 LiabilitiesNoncurrent 552,981
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,635,249
9 ResearchAndDevelopmentExpense 18,700,426
10 remainder_Expenses -36,099
11 remainder_Revenues 0
12 remainder_NetIncome 157,637
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 21,589,790
1 Liabilities 6,082,271
2 Expenses 27,299,576
3 Revenues 0
4 StockholdersEquity 15,507,519
5 NetIncome -27,141,939
6 ComprehensiveNetIncome -27,141,939
7 BaseVar 27,564,637
8 EconomicCapitalRatiobeforeLimitedLiability 0.482
9 EconomicCapitalRatio 1.87

Edgar->Model Mapping

Feature Distribution

Change over Time